4baseCare, an Illumina Accelerator company, that offers precision oncology solutions using advanced genomics and digital health technology, has appointed Francis deSouza to its advisory board.
In deSouza’s decade-long career leading Illumina, he played a key role in making genomics more accessible globally. Under his leadership from 2016 to 2023, Illumina significantly reduced sequencing costs, delivered innovative clinical solutions, and expanded operations to 150+ countries.
Expressing his enthusiasm, Francis deSouza said that 4baseCare has shown remarkable growth over the last 6 years and in his new role and he aims to make a difference in the lives of cancer patients in India and the region. Hitesh Goswami, CEO and co-founder, 4baseCare said that given deSouza’s extensive experience of growing Illumina across geographies, 4baseCare plans to expand its genomics capabilities in SE Asia and the Middle East.